AGP Executive Report

Obesity Drug Watch: Zealand Pharma says Boehringer Ingelheim’s survodutide Phase III data showed up to 34% visceral fat and up to 63% liver fat reductions in people living with obesity, aiming for metabolic benefits with limited lean-mass loss. Women’s Health & Weight: Eli Lilly reports post-hoc analyses from ATTAIN-1 and ATTAIN-2 that women with obesity or overweight taking Foundayo saw significant weight loss across menopause stages, including waist reductions tied to cardiometabolic risk. Liver Disease Breakthrough: Researchers report a hepatitis B “functional cure” with bepirovirsen, with about 1 in 5 patients reaching low enough virus levels for immune control, though durability still needs follow-up. Japan Wellness Trend: A North Country forest-therapy trail in Hermon was certified using a Shinrin-yoku framework, with a guide sharing a breast cancer healing story. Mental Health Safety: Japan’s blue platform lighting is again in the spotlight for suicide-prevention claims, with studies reaching different conclusions on effectiveness. Japan Workforce Reality: Japan’s real wages barely moved despite higher blue-collar pay, as labor shortages push nominal earnings up faster than prices. Healthcare Tech/Policy: Japan’s government panel proposes stricter social media age checks for minors, adding to ongoing child-protection debates.

Lung Transplant Update: Norway’s Crown Princess Mette-Marit has been placed on a lung transplant waiting list after her pulmonary fibrosis worsened, with royal duties postponed as doctors say she needs a transplant soon. Sports Health Spotlight: US gymnast Simone Biles shared that she “almost died” in a recent health scare, posting hospital bracelets and saying she’s been resting while she plans to explain later. Public Health & Safety: A female doctor in Pakistan’s Quetta was seriously injured in an acid attack at Sandeman Provincial Hospital; authorities say the suspect was killed in an encounter and the government is arranging advanced treatment. Japan Care Context: Japan’s Aichi Prefecture reported a stabbing at a factory, with police investigating links to a nearby arson suspect. Wellness & Lifestyle: A Japanese rice-cooker recipe trend highlights easy home cooking that boosts vegetable intake, while a separate piece touts hot springs as a stress- and circulation-friendly wellness option. Healthcare Tech/Access (Global): Ghana is rolling out telehealth for pensioners via SSNIT, NHIA and partner hospitals, aiming to cut travel and wait times for older patients.

Digital Health & AI: Japan-backed WHO/UNDP programme in Ghana will embed AI into the health system with an emphasis on ethical governance, data privacy, digital literacy, and AI-enabled early warning for climate-sensitive diseases. Public Health Access: A feature on India’s healthcare transformation spotlights Ayushman Bharat’s scale—tens of millions of Ayushman cards, large numbers of hospitalisations covered, and major efforts to reduce financial ruin from medical emergencies. Care for Older Adults: Seinan Koreisha Adult Day Care in Los Angeles has received a California state license and is now accepting participants, offering bilingual, bicultural support plus medical and social work consultations. Health Tech in Surgery: Reports highlight a UK-first use of an AI tool that colour-codes the human body during live operations, pointing to faster, clearer surgical guidance. Health & Wellness Education: A Japan-focused course in the Philippines immerses students in deaf education and inclusive employment practices, including learning Filipino Sign Language and accessibility models. Exam & Workforce Pipeline (Health-adjacent): UGC-NET June 2026 schedule was released for CBT exams from June 22–30, with subject-wise dates posted online.

AI in Surgery: UK surgeons used Japan-developed “Eureka” for the first time during a live bowel operation at St Mark’s, with the system color-coding anatomy in real time to help reduce errors. Japan Health Policy & Costs: Japan’s parliament passed a 3.11-trillion-yen supplementary budget for FY2026 to cushion higher energy prices, including subsidies for households and electricity/gas support in summer. Digital Health Data Debate: Japan’s digital minister defended a bill that would let AI developers train on sensitive personal data without consent, arguing it’s needed to avoid an “AI colony” risk as privacy concerns face opposition. Oral Health Promotion: Lion and partners ran Japan’s 83rd National Elementary School Toothbrushing Event on June 5, targeting proper brushing habits at about 6,000 schools and reaching a record ~326,000 participants. COVID Prevention Update: The FDA approved Shionogi’s ensitrelvir (Xocova) as the first oral COVID-19 postexposure prophylaxis option for eligible adults and adolescents. Myopia Watch: New reporting highlights rising childhood myopia in Asia and gaps in early intervention and treatment access.

Myopia Care in Japan: Researchers say Japan’s childhood myopia is rising, but regulatory delays and slower access to myopia control options are creating a gap; newer axial-length measurement devices for children may reduce reliance on cycloplegic drops and help earlier monitoring. Dementia Prevention: A Kyushu University/RIKEN study finds lifestyle factors can lower dementia risk even for people with high genetic susceptibility, including APOE ε4 carriers—supporting targeted prevention rather than one-size-fits-all advice. Maternal Health Alarm (US): A Pennsylvania analysis links nearly half of pregnancy-associated deaths to mental health conditions, with many deaths occurring months after birth—highlighting the need for postpartum mental health support. Japan Energy Relief: Japan approved a 3.1 trillion yen extra budget to cushion rising fuel costs amid Middle East tensions. Hydrogen Drone Logistics (Hiroshima): Robodex and Tokyu Land open Japan’s first permanent hydrogen drone port to keep island supply routes running, including for emergency medicines. Wellness & Food Trends: Matcha demand keeps surging globally, but sourcing and supply constraints are becoming a bigger issue. Public Health & Safety: A Fukushima bear attack injured four and the animal escaped after sliding open a factory window; local schools urged caution. Royal Health (Norway): Crown Princess Mette-Marit was placed on a lung transplant waiting list after serious deterioration.

Myopia Care in Japan: A Tokyo symposium highlights how childhood myopia is rising and why “awareness” isn’t turning into early treatment—clinics are pushing options like atropine, MiSight contact lenses, orthokeratology, and near-work devices to slow progression. Data-Use Rules for AI: Japan’s digital minister warns the country could become an “AI colony” if it falls behind, defending a bill to let AI developers train on sensitive data (including medical and criminal records) without individual consent, while critics flag breach risks. School Heat Safety: A Japan survey finds 1 in 4 students face restrictions on cooling items or drinks at school, and many parents don’t know heat-stress measures like WBGT—raising concerns as summer temperatures climb. Real Wages & Spending: Japan’s real wages rose 1.9% in April for the fourth straight month, but household spending fell 0.5% in real terms, keeping pressure on consumer health and nutrition budgets. Public Health & Environment: UN officials warn mercury pollution from artisanal gold mining is harming women and families through toxic fumes, while Japan’s cedar pollen in Tokyo is about 1.8x last spring, likely worsening allergy symptoms.

Autism Research: A new study reports reversing structural autism-related brain changes in an ASD mouse model, restoring shortened neuron structures and improving social and repetitive-behavior outcomes. Mental Health Access: A former banker-turned-therapist launched Imover, a smartphone app offering self-guided EMDR audio sessions, raising big questions about how evidence-based trauma care can be delivered outside clinics. COVID Prevention: The US FDA approved ensitrelvir (Xocova) as an oral postexposure prophylaxis option for COVID-19 for adults and children 12+ after exposure. Clinical Pipeline: AN2 Therapeutics posted positive enabling data for oral AN2-502998 moving toward Phase 2 for chronic Chagas disease. Japan Health Policy: Japan enacted changes to make childbirth free while raising some prescription drug co-payments, and a separate report flags confusion around hospital cancellation fees ahead of a June launch. Public Health & Safety: US inspectors found serious food safety lapses at restaurants, including moldy salsa, unsafe temperatures, and cross-contamination. Healthcare in the News: Norway’s Crown Princess Mette-Marit visited Oslo’s hospital for care related to her incurable lung illness, with transplant decisions constrained by donor shortages.

Medication Rules Abroad: A health specialist warns holidaymakers that carrying the wrong meds—or packing them poorly—can trigger airport delays, confiscation, and in some countries even fines or criminal charges. Maternal & Child Health: New research links extreme heat to higher preterm birth risk and more childhood hospitalizations for convulsions, as Japan’s summer forecast calls for hotter-than-normal conditions. Pediatric Immunology Drug Update: Pharming says the U.S. FDA accepted its resubmitted application for Joenja (leniolisib) for children aged 4–11 with APDS, with an FDA decision target set for Oct. 24, 2026. Youth Online Safety: A Japan government panel proposes stricter social media age verification and limits on certain features to protect minors’ physical and mental health. Dental Access for U.S. Army Families in Japan: Routine/elective dental care for Camp Zama families is shifting off-base as the on-base clinic reallocates limited resources. Allergy Legacy in Japan: A look at how post-war cedar and cypress reforestation helped forests recover but also fueled today’s widespread pollen allergies. Healthcare Tech & Security: Anthropic expands its AI cybersecurity vulnerability program (Project Glasswing) to more organizations, including healthcare, across multiple countries.

US Forced-Labor Tariffs: The Trump administration has proposed new tariffs of up to 12.5% on imports from 60 economies, including Japan, citing alleged failures to curb goods made with forced labor—an approach trading partners say is unjustified and could raise costs for global supply chains. AI’s Health-Environment Link: A UN report warns data centers powering AI could double electricity and water use by 2030, stressing land and water resources and increasing emissions—an indirect but real public-health concern as infrastructure expands. Maternal Health Inequality: WaterAid’s “Time to Deliver” campaign spotlights what pregnant people pack in hospital bags across 13 countries, including Japan, showing how gaps in basic resources shape maternal outcomes. Newborn Safety Focus: A medical explainer highlights Vitamin K deficiency bleeding (VKDB), why newborns are vulnerable, and how routine Vitamin K injections prevent serious brain, gut, and eye bleeds. Japan Health Policy Watch: Japan has enacted health insurance reforms, including changes that raise some prescription drug co-payments and adjust childbirth-related costs. Brain Science in Japan: Yokohama won the bid to host OHBM 2028, bringing thousands of brain-imaging researchers and clinicians to Japan.

Japan Health Insurance Reform: Japan’s Cabinet has approved health insurance changes that raise patients’ out-of-pocket costs for “OTC-like” prescription drugs from March 2027, while gradually expanding full public coverage for childbirth costs starting around 2028—aimed at easing medical spending and premiums amid demographic decline. Mental Health & AI Use: A new AXA/IPSOS survey finds 68% of people seek mental health advice via AI, but 45% are unhappy with it, with the highest strain among ages 18–24. Cybersecurity AI Access: Anthropic says it will expand access to its Claude Mythos cybersecurity AI to about 150 more organizations, including Japan’s major banks, after earlier limits due to misuse concerns. Dengue Vaccine Review: Philippines authorities say Takeda’s Qdenga vaccine application is still under FDA review three years after submission, as dengue risks rise with the rainy season. Mosquito Repellent Research: New findings suggest mosquitoes can be conditioned to be attracted to DEET, adding a fresh clue to how the widely used repellent works. Bladder Cancer Updates: New trial and subgroup results continue to refine frontline options for HER2+ gastroesophageal cancers, including zanidatamab-based combinations.

Dengue Vaccine Review: Japan-linked Takeda’s Qdenga (TAK-003) remains under review by the Philippines FDA, with officials citing lower efficacy in children aged 4–5 and possible risk concerns tied to dengue serotype 3—while urging continued mosquito control ahead of the rainy season. Cancer Care Research: KORTUC has started enrollment in a Phase 1/2 cervical cancer study testing KRC-01, an intratumoral radiosensitizer aimed at improving outcomes in hypoxic tumors that resist radiation. Oral Cancer Treatment Update: A Phase 3 trial found dexamethasone mouthwash did not significantly reduce oral mucositis in early breast cancer patients, with researchers saying routine prophylactic use isn’t recommended. Japan Pharma IP Move: Akaal Pharma says a Japanese patent has been granted covering its S1P1 agonists (TAKP-119 and OAKP-11), strengthening protection for inflammatory skin disease and itch/pain programs. Regulatory/Access Context: FDA has also approved Xocova as an oral COVID-19 post-exposure prevention option in the U.S., adding to the growing prevention toolbox.

COVID Prevention Breakthrough: Shionogi’s XOCOVA (ensitrelvir) won FDA approval as the first oral post-exposure COVID-19 prevention option for adults and teens 12+, aiming to fill a key gap beyond treatment. Cancer Pipeline Update: Sumitomo Pharma America shared first-in-human Phase 1/2 clinical data for SMP-3124LP, a PEGylated liposome CHK1 inhibitor, presented at ASCO 2026. Rare Disease Access: Santhera said AGAMREE (vamorolone) received orphan drug and fast-track priority review designations in South Korea for Duchenne muscular dystrophy, with a potential faster path to patients. Nutrition & Longevity Spotlight: Nature.com highlighted Saisei Pharma’s MAF research linking nutrition to longevity-related pathways like sarcopenia and telomere biology. Public Health in Practice: A Kumamoto hospital director urged more understanding of Japan’s “baby hatch,” saying it can be a safety net for infants when parents face severe hardship. Safety Alert: Bear attacks in Fukushima City left four people injured, all conscious, as police consider emergency measures to capture the animal.

Japan Health Policy: Japan is moving to raise prescription drug co-payments by aligning some costs with OTC-style pricing, as reforms also aim to make childbirth free while shifting parts of drug costs to patients. Maternal & Preventive Care: More pregnant women in Japan are getting prenatal checkups, signaling a continued push toward earlier, routine care. Public Health & Safety: Japan’s health ministry plans support for organ-transplant hospitals, while a separate report highlights confusion around hospital cancellation fees ahead of a June launch. Healthcare Business & Access: AC Health and Sugi are opening a Japanese-inspired wellness pharmacy in the Philippines, blending everyday wellness products with traditional dispensing. Clinical Research Watch: ASCO 2026 data point to improved outcomes in unresectable hepatocellular carcinoma with a STRIDE + lenvatinib + TACE approach, and multiple ctDNA-guided colon cancer strategies are also being discussed. Wellness & Lifestyle: Cryotherapy for chronic fatigue remains in the spotlight, alongside broader “wellness travel” expansion and new spa-style concepts.

Japan Health & Policy: Japan is preparing a large supplementary budget (over 3.1 trillion yen) to cushion households and municipalities from higher energy costs tied to the Iran conflict, including subsidies for electricity and gas bills and support for LPG users. Clinical Research: New colon cancer results highlight ctDNA-guided adjuvant chemotherapy approaches and related findings, while additional studies report on adjuvant aspirin outcomes in colorectal cancer. Nutrition & Public Health: A Japan-linked study finds nut allergies can be managed beyond strict avoidance, and another global survey flags widespread vitamin D shortfalls in pigs—both underscoring ongoing nutrition gaps. Medical Supply & Industry: Tomoe Shokai plans a medical gas factory in Gujarat for fiscal 2027, aiming to support India’s healthcare and electronics needs. Healthcare Business in Asia: Memphasys secured its first commercial partnership in Southeast Asia for a sperm separation system, with Japan already included in its distribution network. Wellness & Lifestyle: A cycling feature spotlights Japan’s food culture along Shimanami Kaido, mixing healthful travel with local seafood.

Japan-Philippines Health & Wellness Retail: Ayala Healthcare Holdings is launching a “St. Joseph Drug Powered by Sugi” pharmacy concept in Makati, blending trusted dispensing with Japanese preventive-health, skincare and functional wellness products—aimed at rising local demand and returning Filipino tourists. Cancer Drug Update: Summit Therapeutics’ ivonescimab plus chemotherapy showed a statistically significant overall survival gain in China’s HARMONi-6 study for first-line advanced squamous NSCLC, with results set for ASCO presentation. Clinical Oncology Expansion: Johnson & Johnson reported pivotal OrigAMI-4 data on subcutaneous amivantamab plus hyaluronidase for previously treated advanced head and neck cancer, including durable responses and complete responses in a sizable share. Caregiver Mental Health: A new review highlights how informal caregivers of people with mental disorders face high distress levels, underscoring the need for mental-health support for those providing care. Public Health & Travel Demand: Seoul saw a sharp rise in foreign visitors in April, with medical spending up strongly—an indicator of growing healthcare-related travel and spending. Disaster Response (Regional): Laos cave rescue efforts may be delayed by heavy rains and equipment issues, while survivors’ tips are guiding the search for the last two missing miners.

Cancer Drug Update: Exelixis reported new Phase 3 CABINET subgroup results showing CABOMETYX (cabozantinib) improved progression-free survival in advanced neuroendocrine tumors, including both functional and non-functional cases, with data headed to ASCO 2026. Oncology Trial News: Pfizer released detailed TALAPRO-3 results for TALZENNA plus XTANDI in HRR-mutated metastatic castration-sensitive prostate cancer, reporting a 52% risk reduction for radiographic progression or death and rPFS gains at 3 years. Health Tech & Data: Fujitsu, SMBC Group, and SoftBank formed an alliance aimed at building a Japan health data platform, signaling continued push toward digitized healthcare infrastructure. Workplace Health: Japan saw record-high workplace heatstroke cases in 2025, with 1,803 casualties reported—another reminder that prevention needs to keep pace with hotter summers. Public Health Research: Tokyo Metropolitan University researchers linked dopamine pathways to stress-related sexual dysfunction in fruit flies, offering clues that may translate to human conditions. Community Care: Kobe City College of Nursing students toured Seattle’s International Community Health Services clinic, highlighting ongoing Japan-U.S. healthcare exchange and training. Food Safety: Major food recall coverage continued, underscoring ongoing risks from contamination and labeling issues.